• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

安哥拉农村地区结核分枝杆菌复合群耐药情况。

Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.

出版信息

Emerg Infect Dis. 2018 Mar;24(3):569-572. doi: 10.3201/eid2403.171562.

DOI:10.3201/eid2403.171562
PMID:29460748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5823346/
Abstract

We found high prevalence rates of multidrug-resistant tuberculosis among retreatment patients (71.1%) and persons with new cases (8.0%) in Angola. These findings are of concern but should be interpreted with caution. A national drug-resistance survey is urgently needed to determine the actual prevalence of multidrug-resistant tuberculosis in Angola.

摘要

我们发现安哥拉复治患者（71.1%）和新发病例患者（8.0%）中耐多药结核病的流行率很高。这些发现令人担忧，但应谨慎解读。迫切需要进行全国耐药性调查，以确定安哥拉耐多药结核病的实际流行率。

相似文献

1
Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.安哥拉农村地区结核分枝杆菌复合群耐药情况。
Emerg Infect Dis. 2018 Mar;24(3):569-572. doi: 10.3201/eid2403.171562.
2
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.W-北京型和非北京型结核分枝杆菌亚谱系感染的肺结核患者的社会人口学和临床特征比较
Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.
3
Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.北京基因型结核分枝杆菌与中国耐多药和广泛耐药结核病中利奈唑胺耐药显著相关。
Int J Antimicrob Agents. 2014 Mar;43(3):231-5. doi: 10.1016/j.ijantimicag.2013.12.007. Epub 2013 Dec 31.
4
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.俄罗斯结核分枝杆菌分离株对吡嗪酰胺的耐药性：pncA基因测序与Bactec MGIT 960检测的比较
Tuberculosis (Edinb). 2015 Sep;95(5):608-12. doi: 10.1016/j.tube.2015.05.013. Epub 2015 Jun 2.
5
Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.结核分枝杆菌耐药表型谱中吡嗪酰胺耐药的流行情况。
Tuberculosis (Edinb). 2016 Jul;99:128-130. doi: 10.1016/j.tube.2016.05.003. Epub 2016 May 30.
6
Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.印度北方邦疑似耐多药结核病患者的耐药性及相关基因突变
Int J Tuberc Lung Dis. 2016 Jul;20(7):870-5. doi: 10.5588/ijtld.15.0874.
7
Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.黎巴嫩 2016-2017 年耐多药结核病疫情
Emerg Infect Dis. 2019 Mar;25(3):564-568. doi: 10.3201/eid2503.181375.
8
Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.缅甸耐多药结核分枝杆菌临床分离株中的吡嗪酰胺耐药性
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01984-17. Print 2018 Mar.
9
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.结核分枝杆菌的获得性耐药与耐多药结核病患者的不良预后
Emerg Infect Dis. 2015 Jun;21(6):992-1001. doi: 10.3201/eid2106.141873.
10
Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.葡萄牙开展分枝杆菌间隔重复单位分型和耐多药及广泛耐药结核监测的突变特征：3 年期间概述。
Int J Antimicrob Agents. 2014 Dec;44(6):546-51. doi: 10.1016/j.ijantimicag.2014.06.021. Epub 2014 Sep 6.

引用本文的文献

1
The importance of "one health approach" to the AMR study and surveillance in Angola and other African countries.“同一健康方法”对安哥拉及其他非洲国家抗菌药物耐药性研究与监测的重要性。
One Health. 2024 Feb 1;18:100691. doi: 10.1016/j.onehlt.2024.100691. eCollection 2024 Jun.
2
Stigma among tuberculosis patients and associated factors in urban slum populations in Uganda.乌干达城市贫民窟中结核病患者的污名化及其相关因素。
Afr Health Sci. 2021 Dec;21(4):1640-1650. doi: 10.4314/ahs.v21i4.18.
3
Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant in Zambia.赞比亚耐多药结核中与链霉素耐药相关突变的特征分析
Antibiotics (Basel). 2021 Sep 26;10(10):1169. doi: 10.3390/antibiotics10101169.
4
Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola.安哥拉共和国古巴省结核分枝杆菌分离株 rpoB 基因突变的分子特征。
BMC Infect Dis. 2021 Oct 12;21(1):1056. doi: 10.1186/s12879-021-06763-8.
5
Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis.高负担国家中结核病患者普遍药物敏感性测试与选择性药物敏感性测试的差异产量：系统评价和荟萃分析。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003438.
6
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola.安哥拉农村地区标准化耐多药结核病方案的治疗结果和不良事件。
Am J Trop Med Hyg. 2019 Sep;101(3):502-509. doi: 10.4269/ajtmh.19-0175.

本文引用的文献

1
The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.赋予耐药性突变的适合度代价分布是耐多药结核病未来负担的关键决定因素：基于模型的分析
Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S147-54. doi: 10.1093/cid/civ579.
2
The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.第二次赞比亚全国结核病耐药性调查——传统方法与分子方法的比较
Trop Med Int Health. 2015 Nov;20(11):1492-1500. doi: 10.1111/tmi.12581. Epub 2015 Aug 27.
3
Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.博茨瓦纳抗结核药物耐药性增加：第四次全国耐药性调查结果
Int J Tuberc Lung Dis. 2014 Sep;18(9):1026-33. doi: 10.5588/ijtld.13.0749.
4
Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China.基因型 MTBDRplus 在华南地区大容量实验室中快速检测结核分枝杆菌复合群及其对异烟肼和利福平耐药性的应用。
Mol Biol Rep. 2011 Mar;38(3):2185-92. doi: 10.1007/s11033-010-0347-0. Epub 2010 Sep 18.
5
Mycobacterium tuberculosis: drug resistance and future perspectives.结核分枝杆菌：耐药性与未来展望。
Future Microbiol. 2009 Jun;4(5):597-614. doi: 10.2217/fmb.09.20.
6
The mechanism of isoniazid killing: clarity through the scope of genetics.异烟肼杀菌机制：通过遗传学范畴得以明晰。
Annu Rev Microbiol. 2007;61:35-50. doi: 10.1146/annurev.micro.61.111606.122346.
7
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.异烟肼耐药突变及耐多药结核分枝杆菌进化的群体遗传学研究
Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9. doi: 10.1128/AAC.00112-06.
8
Isoniazid resistance and the future of drug-resistant tuberculosis.异烟肼耐药性与耐多药结核病的未来。
Microb Drug Resist. 2004 Winter;10(4):280-5. doi: 10.1089/mdr.2004.10.280.